ACUTA CAPITAL PARTNERS, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$86.2B
Holdings
34
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OCULOCULAR THERAPEUTIX INC | 1,219,724 | $8.9B | 10.37% | |
| 2 | IM8NINSMED INC | 106,074 | $8.1B | 9.38% | |
| 3 | TRMLTOURMALINE BIO INC | 426,882 | $6.5B | 7.53% | |
| 4 | WHWKWHITEHAWK THERAPEUTICS INC | 3,410,402 | $6.1B | 7.04% | |
| 5 | ELVNENLIVEN THERAPEUTICS INC | 265,269 | $5.2B | 6.05% | |
| 6 | TRVITREVI THERAPEUTICS INC | 785,961 | $4.9B | 5.73% | |
| 7 | SLNOSOLENO THERAPEUTICS INC | 67,136 | $4.8B | 5.56% | |
| 8 | ARGXARGENX SE | 7,023 | $4.2B | 4.82% | |
| 9 | ASNDASCENDIS PHA-ADR | 23,340 | $3.6B | 4.22% | |
| 10 | PRAXPRAXIS PRECISION MEDICINES I | 87,141 | $3.3B | 3.83% | |
| 11 | CDTXCIDARA THERAPEUTICS INC | 125,708 | $2.7B | 3.14% | |
| 12 | OCSOCULIS HOLDING AG | 125,000 | $2.4B | 2.76% | |
| 13 | RVMDREVOLUTION MEDICINES INC | 66,662 | $2.4B | 2.73% | |
| 14 | LQDALIQUIDIA CORPORATION | 153,482 | $2.3B | 2.63% | |
| 15 | DRUGBRIGHT MINDS BIOSCIENCES INC | 59,748 | $2.2B | 2.50% | |
| 16 | HLXCHELIX ACQUISITION CORP II | 187,257 | $2.1B | 2.45% | |
| 17 | MRKMERCK & CO | 22,994 | $2.1B | 2.39% | |
| 18 | SRZNSURROZEN INC | 170,000 | $2.0B | 2.30% | |
| 19 | EWTXEDGEWISE THERAPEUTICS INC | 85,454 | $1.9B | 2.18% | |
| 20 | MREOMEREO BIOPHARMA GROUP PL-ADR | 791,815 | $1.8B | 2.07% | |
| 21 | UNCYUNICYCIVE THERAPEUTICS INC | 2,352,887 | $1.4B | 1.57% | |
| 22 | JAZZJAZZ PHARMACEUTICALS PLC | 9,575 | $1.2B | 1.38% | |
| 23 | VSTMVERASTEM INC | 176,000 | $1.1B | 1.23% | |
| 24 | GILDGILEAD SCIENCES INC | 9,298 | $1.0B | 1.21% | |
| 25 | TERNTERNS PHARMACEUTICALS INC | 325,550 | $898.5M | 1.04% | |
| 26 | ZYMEZYMEWORKS INC | 68,459 | $815.3M | 0.95% | |
| 27 | RAREULTRAGENYX PHARMACEUTICAL INC | 21,290 | $770.9M | 0.89% | |
| 28 | VERVVERVE THERAPEUTICS INC | 162,724 | $743.6M | 0.86% | |
| 29 | RCKTROCKET PHARMACEUTICALS INC | 83,350 | $555.9M | 0.64% | |
| 30 | RAPPRAPPORT THERAPEUTICS INC | 16,400 | $164.5M | 0.19% | |
| 31 | FBRXFORTE BIOSCIENCES INC | 18,469 | $143.3M | 0.17% | |
| 32 | ARTVARTIVA BIOTHERAPEUTICS INC | 45,456 | $136.4M | 0.16% | |
| 33 | NUVB/WSNUVATION BIO INC -CW27 | 90,832 | $17.5M | 0.02% | |
| 34 | ELVNENLIVEN THERAPEUTICS INC | 115,805 | $0 | 0.00% |